loading

Finanzdaten der Inhibikase Therapeutics Inc-Aktie (IKT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
0.000001 0.0796 0.1164 0.0645
Selling, General, and Administrative
2.0311
- - - -
Costs And Expenses
8.60%
4.7824
4.4036 4.8484 6.3188 4.7795
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
8.60%
-4.7824
-4.4036 -4.7689 -6.2024 -4.7149
Net Interest Income/Expense
41.17%
0.1327
0.2256 0.1737 0.4244 0.2372
Interest Income/Expense After Provision For Losses
41.17%
0.1327
0.2256 0.1737 0.4244 0.2372
Income/Loss From Continuing Operations Before Tax
8.60%
-4.7824
-4.4036 -4.7689 -5.778 -4.4778
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
11.29%
-4.6496
-4.1779 -4.5952 -5.778 -4.4778
Net Income/Loss
11.29%
-4.6496
-4.1779 -4.5952 -5.778 -4.4778
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,226%
6.3407
0.2726 5.3423 5.2261 27.51
Diluted Average Shares
2,226%
6.3407
0.2726 5.3423 5.2261 27.51
Basic Earnings Per Share
14.06%
-0.73
-0.64 -0.86 -1.11 -0.16
Diluted Earnings Per Share
14.06%
-0.73
-0.64 -0.86 -1.11 -0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
Kapitalisierung:     |  Volumen (24h):